EMA ‘Needs More Resources’ If EU Rolling Reviews Are To Be Used More Widely
Executive Summary
An assessment of the European Medicines Agency’s performance in tackling the COVID-19 pandemic shows that the agency was “well prepared” with a crisis management plan but that it faced a range of challenges such as the fallout from Brexit, a heavy workload and how to maintain the public’s trust in medicines regulation.